This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 600+ CE and professional development courses.

Get access starting at $49.95/yrLoading..

Goals and Learning Outcomes

Hypercoagulability disorder is a common clinical condition characterized by abnormal blood coagulation, resulting in the formation of blood clots within one’s vasculature. Venous thromboembolism (VTE), or a blood clot found in the veins, is predominantly displayed as deep vein thrombosis (DVT) or pulmonary embolism (PE) (Centers for Disease Control and Prevention, 2022d). DVT may result from the formation of blood clots in the peripheral vascular bed. VTE can occur in multiple sites, including the veins in the lungs, brain, kidneys, liver, mesenteric circulation, arms, and legs. The challenge in managing hypercoagulability disorders is due to the clinical variability of the disease etiology and numerous possible sites of blockage balanced against treatment objectives, outcomes, and cost.

 

The goal of this course is to provide nurses, pharmacists, dietitians, and physicians in the acute care setting with knowledge of the concept of hypercoagulability and the various features, risk factors, and evidence-based guidelines for prophylaxis and treatment of VTE.


After taking this course, you should be able to:

  • Identify the concepts of coagulation and hemostasis.
  • Recognize the risk factors, symptoms, tests, and diagnostic tools of VTE.
  • Recall the treatment modalities and goals of therapy for VTE, using evidence-based practice guidelines for prevention and treatment.
  • Determine key points of patient education and the challenges with patient adherence to anticoagulant therapy.

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/25

Course Originally Released On: 11/01/22

Course Authors

4.5 Average

Course Reviews

7285 reviews

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.